The latest episode of Thinking Thoracic dives into one of the most challenging diseases in thoracic oncology—malignant pleural mesothelioma. Host Erin Gillaspie, MD, speaks with Joshua Reuss, MD, a thoracic medical oncologist and clinical trials leader, about how immunotherapy, evolving surgical strategies, and global practice patterns are reshaping care for this rare cancer.
The episode covers the impact of the Checkmate 743 trial, controversy surrounding the MARS-2 surgical study, promising results from neoadjuvant immunotherapy trials, and the critical need for collaboration and clinical trial enrollment to drive progress.
Listen now to explore where mesothelioma research is headed and what it means for patient care.

<description>&lt;p&gt;The latest episode of Thinking Thoracic dives into one of the most challenging diseases in thoracic oncology—malignant pleural mesothelioma. Host Erin Gillaspie, MD, speaks with Joshua Reuss, MD, a thoracic medical oncologist and clinical trials leader, about how immunotherapy, evolving surgical strategies, and global practice patterns are reshaping care for this rare cancer.&lt;/p&gt;
&lt;p&gt;The episode covers the impact of the Checkmate 743 trial, controversy surrounding the MARS-2 surgical study, promising results from neoadjuvant immunotherapy trials, and the critical need for collaboration and clinical trial enrollment to drive progress.&lt;/p&gt;
&lt;p&gt;Listen now to explore where mesothelioma research is headed and what it means for patient care.&lt;/p&gt;
</description>

Host Erin Gillaspie, MD, speaks with Joshua Reuss, MD, a thoracic medical oncologist and clinical trials leader, about how immunotherapy, evolving surgical strategies, and global practice patterns are reshaping care for this rare cancer.

#17, S2 The Future of Mesothelioma Treatment

The occupation we have chosen is the most fulfilling job in the world. Cardiothoracic surgery has been the only career I have pursued as an adult, but I know that even without a meaningful comparison, my bold claim is correct. We have studied and practiced for years to acquire skills so that we can help to cure our patients or at least minimize their suffering. Yet, throughout all of our careers, having a patient succumb to their disease, or our attempt at treating their disease, is as much of a certainty as our own eventual mortality. Read this blog by Dr. Derek Serna-Gallegos on how to face your first patient death as a cardiothoracic surgeon.

<description>&lt;p&gt;The occupation we have chosen is the most fulfilling job in the world. Cardiothoracic surgery has been the only career I have pursued as an adult, but I know that even without a meaningful comparison, my bold claim is correct. We have studied and practiced for years to acquire skills so that we can help to cure our patients or at least minimize their suffering. Yet, throughout all of our careers, having a patient succumb to their disease, or our attempt at treating their disease, is as much of a certainty as our own eventual mortality. Read this blog by Dr. Derek Serna-Gallegos on how to face your first patient death as a cardiothoracic surgeon.&lt;/p&gt;
</description>

The occupation we have chosen is the most fulfilling job in the world. Cardiothoracic surgery has been the only career I have pursued as an adult, but I know that even without a meaningful comparison, my bold claim is correct. We have studied and practiced for years to acquire skills so that we can help to cure our patients or at least minimize their suffering. Yet, throughout all of our careers, having a patient succumb to their disease, or our attempt at treating their disease, is as much of a certainty as our own eventual mortality. Read this blog by Dr. Derek Serna-Gallegos on how to face your first patient death as a cardiothoracic surgeon.

Facing Your First Patient Death as an Attending Surgeon

In this special episode of Same Surgeon, Different Light, hosts Dr. Cherie Erkmen and Dr. Sara Pereira sit down with STS President Dr. Joseph Sabik as he reflects on his early interest science, the mentors who shaped his career, and the pivotal role mentorship continues to play in his leadership within the Society.
He also shares insights into what attendees can anticipate at the 62nd STS Annual Meeting, unpacks the meaning behind this year’s theme—“Teaching for Tomorrow Together”—and offers an exclusive preview of the inspiring speakers and events that will celebrate the specialty’s future.

<description>&lt;p&gt;In this special episode of Same Surgeon, Different Light, hosts Dr. Cherie Erkmen and Dr. Sara Pereira sit down with STS President Dr. Joseph Sabik as he reflects on his early interest science, the mentors who shaped his career, and the pivotal role mentorship continues to play in his leadership within the Society.&lt;/p&gt;
&lt;p&gt;He also shares insights into what attendees can anticipate at the 62nd STS Annual Meeting, unpacks the meaning behind this year’s theme—“Teaching for Tomorrow Together”—and offers an exclusive preview of the inspiring speakers and events that will celebrate the specialty’s future.&lt;/p&gt;
</description>

In this special episode of Same Surgeon, Different Light, hosts Dr. Cherie Erkmen and Dr. Sara Pereira sit down with STS President Dr. Joseph Sabik as he reflects on his early interest science, the mentors who shaped his career, and the pivotal role mentorship continues to play in his leadership within the Society.
He also shares insights into what attendees can anticipate at the 62nd STS Annual Meeting, unpacks the meaning behind this year’s theme—“Teaching for Tomorrow Together”—and offers an exclusive preview of the inspiring speakers and events that will celebrate the specialty’s future.

171; S5: Same Surgeon, Different Light w/ STS President Joseph Sabik, MD

In this episode of Thinking Thoracic, host Dr. Erin Gillaspie talks with Dr. Robert Lentz and Dr. Fabien Maldonado about the groundbreaking VERITAS trial, which is reshaping how clinicians diagnose lung cancer. Published in the New England Journal of Medicine, the VERITAS trial compared navigational bronchoscopy with CT-guided biopsy in a rigorous, randomized design, bringing much-needed evidence to interventional pulmonology. The discussion explores how the study was conceived, why robust device trials are vital to patient outcomes, and what the findings mean for the future of minimally invasive lung diagnostics.

<description>&lt;p&gt;In this episode of Thinking Thoracic, host Dr. Erin Gillaspie talks with Dr. Robert Lentz and Dr. Fabien Maldonado about the groundbreaking VERITAS trial, which is reshaping how clinicians diagnose lung cancer. Published in the New England Journal of Medicine, the VERITAS trial compared navigational bronchoscopy with CT-guided biopsy in a rigorous, randomized design, bringing much-needed evidence to interventional pulmonology. The discussion explores how the study was conceived, why robust device trials are vital to patient outcomes, and what the findings mean for the future of minimally invasive lung diagnostics.&lt;/p&gt;
</description>

This episode of Thinking Thoracic explores the VERITAS trial, which compared navigational bronchoscopy with CT-guided biopsy in a rigorous, randomized design, bringing much-needed evidence to interventional pulmonology.

#16, S1 How the VERITAS Trial Has Transformed Lung Cancer Diagnosis

Whether you are a thoracic surgeon and you are going to break through the ceiling on survival for mesothelioma, an adult cardiac surgeon tackling structural valve deterioration, or a community cardiothoracic surgeon improving outcomes for ECMO patients, identifying and building a niche is exciting and rewarding. In this blog article, hear from Dr. Brian Bateson on how you can successfully build a niche with care, passion, and understanding.

<description>&lt;p&gt;Whether you are a thoracic surgeon and you are going to break through the ceiling on survival for mesothelioma, an adult cardiac surgeon tackling structural valve deterioration, or a community cardiothoracic surgeon improving outcomes for ECMO patients, identifying and building a niche is exciting and rewarding. In this blog article, hear from Dr. Brian Bateson on how you can successfully build a niche with care, passion, and understanding.&lt;/p&gt;
</description>

Whether you are a thoracic surgeon and you are going to break through the ceiling on survival for mesothelioma, an adult cardiac surgeon tackling structural valve deterioration, or a community cardiothoracic surgeon improving outcomes for ECMO patients, identifying and building a niche is exciting and rewarding. In this blog article, hear from Dr. Brian Bateson on how you can successfully build a niche with care, passion, and understanding.

How to Build Your Niche Without Losing Your Soul

Listen to leaders in cardiothoracic surgery discuss hot topics in the field. Please note: The comments included in these episodes are that of the individuals involved and not necessarily that of The Society of Thoracic Surgeons.

Surgical Hot Topics

Details

Recent Episodes